Page last updated: 2024-12-08

bulleyaconitine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

bulleyaconitine A: isolated from Aconitum bulleyanum Diel; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AconitumgenusA plant genus of the family RANUNCULACEAE. Members contain a number of diterpenoid alkaloids including: aconitans, hypaconitine, ACONITINE, jesaconitine, ignavine, napelline, and mesaconitine. The common name of Wolfbane is similar to the common name for ARNICA.[MeSH]RanunculaceaeThe buttercup plant family of the order RANUNCULALES, class MAGNOLIOPSIDA. The leaves are usually alternate and stalkless. The flowers usually have two to five free sepals and may be radially symmetrical or irregular.[MeSH]
Aconitum bulleyanumspecies[no description available]RanunculaceaeThe buttercup plant family of the order RANUNCULALES, class MAGNOLIOPSIDA. The leaves are usually alternate and stalkless. The flowers usually have two to five free sepals and may be radially symmetrical or irregular.[MeSH]

Cross-References

ID SourceID
PubMed CID124605141
MeSH IDM0149035

Synonyms (2)

Synonym
bulleyaconitine a
107668-79-1

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The validated method was successfully applied to pharmacokinetic study in rat after single oral administration of 40μg/kg of BLA and the oral pharmacokinetic data of BLA have been demonstrated for the first time."( Determination of bulleyaconitine A in plasma by a sensitive LC-MS/MS method and its application to an oral pharmacokinetic study in rats.
Gong, Y; Ji, G; Li, W; Shen, T; Tan, B; Wang, Q; Yang, P; Zhang, Y, 2012
)
0.38

Compound-Compound Interactions

ExcerptReferenceRelevance
" The major metabolic pathways of BLA in rat liver microsomes were clarified by HPLC-MS combined with specific inhibitors of CYP450 isoforms."( Studies on metabolites and metabolic pathways of bulleyaconitine A in rat liver microsomes using LC-MS(n) combined with specific inhibitors.
Bi, Y; Liu, S; Liu, Z; Song, F; Zhu, H; Zhuang, X, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.76)18.7374
1990's0 (0.00)18.2507
2000's5 (23.81)29.6817
2010's11 (52.38)24.3611
2020's4 (19.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]